Product news

Share this article:
Mylan has received final FDA approval for its fluoxetine capsules—10 mg and 20 mg—a generic form of Lilly's antidepressant, Sarafem Pulvules Capsules. Sarafem Pulvules Capsules brought in roughly $19.2 million for the 12 months ending Sept. 30, according to IMS Health. 
 
Two Johnson & Johnson subsidiaries (Janssen and ALZA) were found liable in the death of a Cicero, IL, woman, who died while using a Duragesic patch. A Chicago court awarded Janice DiCosolo's family with $16.5 million. DiCosolo's family argued that the defendants were aware of the patch's defect, which caused fentanyl to leak in large enough amounts to be fatal. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.